Skip to main content
. 2015 Oct 14;21(38):10866–10873. doi: 10.3748/wjg.v21.i38.10866

Figure 1.

Figure 1

Five-year overall survival of gastric cancer patients based on hepatoduodenal lymph node metastasis. A: All 276 patients analysed in this study were divided into two groups based on hepatoduodenal lymph node (HDLN) metastasis. A group with HDLN metastasis (n = 26) and that without HDLN metastasis (n = 250) were compared. Kaplan-Meier survival curves were statistically analysed by the log-rank test (P < 0.0001); B: The patients who had lymph node metastasis (n = 145) were divided into two groups and analysed as described in panel a (26 patients with HDLN metastasis and 119 patients without HDLN metastasis, P < 0.0001).